4//SEC Filing
REICIN ALISE 4
Accession 0000899243-22-023064
CIK 0001661998other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:05 PM ET
Size
5.5 KB
Accession
0000899243-22-023064
Insider Transaction Report
Form 4
REICIN ALISE
Director
Transactions
- Award
Option (Right to Buy)
2022-06-15+18,000→ 18,000 totalExercise: $1.88Exp: 2032-06-15→ Common Stock (18,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable on the earlier of June 15, 2023 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.
Documents
Issuer
Homology Medicines, Inc.
CIK 0001661998
Entity typeother
Related Parties
1- filerCIK 0001757533
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:05 PM ET
- Size
- 5.5 KB